The recommended age to start screening for colorectal cancer was lowered in 2021 from 50 to 45 for people of average risk.

Viome Life Sciences, the leader in AI-powered, RNA-based diagnostics and precision nutrition and  Scripps Research, the ...

A test developed by a Madison company to better track cancer DNA in the blood stream will now be covered by Medicare.

You may have seen print or television ads promoting the Galleri blood test for “early cancer detection.” Neither this test nor any others are covered by Medicare or commercial insurance, but you can ...

I had a symptom of colon cancer and family history, so I got a colonoscopy. It was expensive, and insurance was a nightmare, ...

RNA-based liquid biopsy developed at the University of Chicago detects early-stage colorectal cancer with 95% accuracy using ...

Feeling tired all the time is another possible symptom. Colon cancer can lead to slow, long-term blood loss in the stool, ...

In an average-risk colorectal cancer screening population, a blood-based circulating tumor DNA test is feasible.

To develop the test, researchers analyzed 6553 blood samples, 3076 from patients with cancer and 3477 from healthy ...

A study from the University of Chicago introduces an RNA-based liquid biopsy that detects early-stage colorectal cancer with ...

A promising new approach to the early detection of colorectal cancer, or CRC for short, has now been presented in the journal ...